Consonance Capital Partners
Private Capital for Healthcare
in the Middle Market
Consonance Capital Partners (“CCP”) is a private equity manager focused exclusively on investing in the healthcare industry. CCP’s founders, Mitchell Blutt, MD, Benjamin Edmands, Stephen McKenna, and Nancy-Ann DeParle, partnered together for over a decade while at JPMorgan Partners and its successor and predecessor entities (collectively “JPMP”), and have over 90 years of combined experience in private equity investing, primarily within healthcare. To date, CCP has raised over $1.3 billion in equity capital across two funds, and CCP is currently investing out of Consonance Private Equity II, L.P. With a history of successfully investing across multiple healthcare sub-sectors, Consonance Capital Partners brings a wealth of experience, insights, and an extensive network of relationships to existing and prospective management teams and portfolio companies.
CCP seeks to partner with world-class management teams in subsectors that have high growth opportunities. The firm takes a collaborative approach to these relationships and believes that strong managers with aligned incentives are the backbone of a successful investment strategy. In addition, CCP has a robust history of working together with large corporations which are seeking to divest non-core assets and private/family-owned businesses which are seeking liquidity, growth capital, or both from knowledgeable, experienced, and partner-oriented healthcare investors.